| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/12/2013 | US20130237531 Compounds and methods for kinase modulation, and indications therefor |
| 09/12/2013 | US20130237526 Pharmaceutical composition |
| 09/12/2013 | US20130237519 Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension |
| 09/12/2013 | US20130237518 Novel compounds that are erk inhibitors |
| 09/12/2013 | US20130237499 Inhibitors of Human Immunodeficiency Virus Replication |
| 09/12/2013 | US20130237494 Bone-targeting bisphosphonate duplex drugs |
| 09/12/2013 | US20130237492 Use of 2',5'-oligoadenylate derivative compounds |
| 09/12/2013 | US20130237491 4'-substituted nucleoside derivatives as inhibitors of hcv rna replication |
| 09/12/2013 | US20130237479 Composition for controlled ovarian stimulation |
| 09/12/2013 | US20130237478 Compositions and methods for treatment of peripheral vascular disease |
| 09/12/2013 | US20130237477 Compositions and methods for increasing vascularization |
| 09/12/2013 | US20130236573 Esketamine for the treatment of treatment-refractory or treatment-resistant depression |
| 09/12/2013 | US20130236572 Systems and methods for treating fibromyalgia |
| 09/12/2013 | US20130236568 Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof |
| 09/12/2013 | US20130236553 Compositions and Methods for the Delivery of Therapeutics |
| 09/12/2013 | US20130236551 Combination composition useful for treating cardiovascular diseases |
| 09/12/2013 | US20130236536 Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein |
| 09/12/2013 | US20130236535 Antibodies |
| 09/12/2013 | US20130236525 Sustained release intraocular implants and related methods |
| 09/12/2013 | US20130236508 Method of treatment |
| 09/12/2013 | US20130236483 Fgf modulation of in vivo antibody production and humoral immunity |
| 09/12/2013 | US20130236480 Transglutaminase 2 inhibitors for use in the prevention or treatment of rapidly progressive glomerulonephritis |
| 09/12/2013 | US20130236477 Methods for Promoting Reinnervation of Auditory Hair Cells |
| 09/12/2013 | US20130236472 Compounds and mixtures for influencing inflammatory states |
| 09/12/2013 | US20130236468 Benzodioxane inhibitors of leukotriene production for combination therapy |
| 09/12/2013 | US20130236458 Dual specific binding proteins directed against il-13 and/or il-17 |
| 09/12/2013 | US20130236449 Methods of enhancing antibody-dependent cellular cytotoxicity |
| 09/12/2013 | US20130236426 Use of decorin for increasing muscle mass |
| 09/12/2013 | US20130236420 Silibinin component for the treatment of hepatitis |
| 09/12/2013 | DE102012004589A1 New angiotensin II-receptor agonist, useful for treating neurodegenerative diseases, preferably Alzheimer's dementia, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis |
| 09/11/2013 | EP2636742A1 Induction of exon skipping in eukaryotic cells |
| 09/11/2013 | EP2636741A1 Induction of exon skipping in eukaryotic cells |
| 09/11/2013 | EP2636740A1 Induction of exon skipping in eukaryotic cells |
| 09/11/2013 | EP2636414A1 Preventive or therapeutic agent for pain associated with herpes zoster in acute phase |
| 09/11/2013 | EP2636409A1 Combined pharmaceutical composition as antifungal agent |
| 09/11/2013 | EP2635291A1 Plant extracts for treating burns and chronic wounds |
| 09/11/2013 | EP2635276A2 Composition and method for treating skin conditions |
| 09/11/2013 | EP2635268A1 Pharmaceutical combinations for the treatment of metabolic disorders |
| 09/11/2013 | EP2635266A1 Composition and drug containing omega-3 fatty acids, and a modulator |
| 09/11/2013 | EP2635260A2 Compositions and methods for the delivery of therapeutics |
| 09/11/2013 | EP2635250A1 Dye composition having a low content of ammonia |
| 09/11/2013 | CN1957909B Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms |
| 09/11/2013 | CN103298481A Use of prolactin receptor antagonist and chemotherapeutic drug for treating ovarian cancer |
| 09/11/2013 | CN103298466A Methods for concomitant treatment of theophylline and febuxostat |
| 09/11/2013 | CN103293316A A method of diagnosis and treatment |
| 09/11/2013 | CN103290112A Application of CCDC158 gene in preparation of liver cancer treatment or diagnosis medicament |
| 09/11/2013 | CN103290101A Ago2 gene and application of expression product thereof |
| 09/11/2013 | CN103290017A HER2 (Human Epidermal Growth Factor Receptor 2) protein nucleotide aptamer, complex composition and applications thereof |
| 09/11/2013 | CN103288793A Phenethanolamine derivatives for treatment of respiratory diseases |
| 09/11/2013 | CN103288721A (4-(4-[6-(trifluoromethyl-pyridin-3-ylamino)-n-containing-heteroaryl]-phenyl)-cyclohexyl)-acetic acid derivatives and pharmaceutical uses thereof |
| 09/11/2013 | CN103285398A Compound preparation containing DPP-IV (dipeptidyl peptidase-IV) inhibitor and type-II diabetes medicine and preparation method thereof |
| 09/11/2013 | CN103285397A External compound medicine for treating acne |
| 09/11/2013 | CN103285396A Medicine composition for eradicating helicobacter pylori, as well as preparation method and application |
| 09/11/2013 | CN103285395A Combinations and modes of administration of therapeutic agents and combination therapy |
| 09/11/2013 | CN103285394A Use of nitrated lipids for treatment of lipid disorders and obesity, and lipid- and obesity-related conditions |
| 09/11/2013 | CN103285029A Xanthan gum-containing preparation for treating burns and scalds |
| 09/11/2013 | CN103284971A Tablets with site- and time- controlled gastrointestinal release of active ingredient |
| 09/11/2013 | CN103284951A Photosensitive liposome with encapsulated water-soluble medicament |
| 09/11/2013 | CN102000341B Polyethylene oxide and matrix type surfactant in suppository composition |
| 09/11/2013 | CN101928288B Small molecule compositions for binding to HSP90 |
| 09/11/2013 | CN101810583B HIV (Human Immunodeficiency Virus) fusion inhibitor slow-release microsphere |
| 09/11/2013 | CN101489591B Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 09/10/2013 | US8530498 Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione |
| 09/10/2013 | US8530225 Therapeutic agents comprising pro-apoptotic proteins |
| 09/10/2013 | US8530209 Method for producing probiotically derived compounds |
| 09/10/2013 | US8529940 Dietary method for modulating glucose metabolism |
| 09/10/2013 | US8529932 Polymers of fluorinated monomers and hydrocarbon monomers |
| 09/10/2013 | US8529931 Polymers of fluorinated monomers and hydrocarbon monomers |
| 09/10/2013 | US8529930 Polymers of fluorinated monomers and hydrocarbon monomers |
| 09/10/2013 | US8529906 Compositions for inducing immune responses |
| 09/10/2013 | US8529884 Using vector transformation to express herpes simple-1 viral gene sequences in cells; inducing immune response to pathogen attack |
| 09/10/2013 | US8529882 Peptidomimetic protease inhibitors |
| 09/10/2013 | CA2755452C Method of regulating glucose metabolism, and reagents related thereto |
| 09/10/2013 | CA2650572C Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 09/10/2013 | CA2579501C Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 09/10/2013 | CA2539568C Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects |
| 09/10/2013 | CA2529027C D-amino acid peptides |
| 09/10/2013 | CA2492498C Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 09/10/2013 | CA2456247C Use of il-18 inhibitors in hypersensitivity disorders |
| 09/10/2013 | CA2427340C Cyp1b1 nucleic acids and methods of use |
| 09/10/2013 | CA2413237C Alteration of cell membrane for new functions |
| 09/10/2013 | CA2331789C Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 09/06/2013 | WO2013130917A1 Interleukin-3 polypeptide conjugates their uses |
| 09/06/2013 | WO2013130832A1 Combination therapy for treating androgen deficiency |
| 09/06/2013 | WO2013130773A2 Compositions of microbiota and methods related thereto |
| 09/06/2013 | WO2013130538A2 Method of treating chronic obstructive pulmonary disease |
| 09/06/2013 | WO2013129931A1 Method for improving functional synaptic connectivity |
| 09/06/2013 | WO2013129914A1 Method for improving functional synaptic connectivity |
| 09/06/2013 | WO2013128450A1 Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes |
| 09/05/2013 | US20130231519 1H-Pyrrolo[2,3 b]pyridine derivatives |
| 09/05/2013 | US20130231518 Compounds and compositions for mitigating tissue damage and lethality |
| 09/05/2013 | US20130231387 Prevention of proteomic and genomic damage by dicarbonyl substrates of glo 1 |
| 09/05/2013 | US20130231384 Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory |
| 09/05/2013 | US20130231365 Treatment of Inflammation with Certain Alpha-7 Nicotinic Acid Receptor Agonists in Combination with Acetylcholinesterase Inhibitors |
| 09/05/2013 | US20130231347 Method of treatment with braf inhibitor |
| 09/05/2013 | US20130231346 Methods of treating cancer |
| 09/05/2013 | US20130231329 Benzazole Derivatives as Histamine H4 Receptor Ligands |
| 09/05/2013 | US20130231326 Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
| 09/05/2013 | US20130231315 Modified 4-phenyl-pyridine derivatives |
| 09/05/2013 | US20130231314 Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione |